Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Page 1
Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort.
Korenblik R, Heil J, Smits J, James S, Olij B, Bechstein WO, Bemelmans MHA, Binkert CA, Breitenstein S, Williams M, Detry O, Dewulf MJL, Dili A, Grochola LF, Grote J, Heise D, Kalil JA, Metrakos P, Neumann UP, Pappas SG, Pennetta F, Schnitzbauer AA, Tasse JC, Winkens B, Olde Damink SWM, van der Leij C, Schadde E, van Dam RM; DRAGON trials collaborative. Korenblik R, et al. Among authors: van dam rm. Br J Surg. 2024 Apr 3;111(4):znae087. doi: 10.1093/bjs/znae087. Br J Surg. 2024. PMID: 38662462 Free PMC article.
Association of modified textbook outcome and overall survival after surgery for colorectal liver metastases: A nationwide analysis.
Voigt KR, de Graaff MR, Verhoef C, Kazemier G, Swijneburg RJ, Mieog JSD, Derksen WJM, Buis CI, Gobardhan PD, Dulk MD, van Dam RM, Liem MSL, Leclercq WKG, Bosscha K, Belt EJT, Vermaas M, Kok NFM, Patijn GA, Marsman HM, van den Boezem PB, Klaase JM, Grünhagen DJ; Dutch Hepato Biliary Audit Group, Collaborators. Voigt KR, et al. Among authors: van dam rm. Eur J Surg Oncol. 2024 Mar;50(3):107972. doi: 10.1016/j.ejso.2024.107972. Epub 2024 Jan 20. Eur J Surg Oncol. 2024. PMID: 38278128 Free article.
BACKGROUND: Textbook outcome (TO) represents a multidimensional quality measurement, encompassing the desirable short-term outcomes following surgery. This study aimed to investigate whether achieving TO after resection of colorectal liver metastases (CRLM) surgery is rela …
BACKGROUND: Textbook outcome (TO) represents a multidimensional quality measurement, encompassing the desirable short-term outcomes f …
Effectiveness of holistic mobile health interventions on diet, and physical, and mental health outcomes: a systematic review and meta-analysis.
Zheng S, Edney SM, Goh CH, Tai BC, Mair JL, Castro O, Salamanca-Sanabria A, Kowatsch T, van Dam RM, Müller-Riemenschneider F. Zheng S, et al. Among authors: van dam rm. EClinicalMedicine. 2023 Nov 18;66:102309. doi: 10.1016/j.eclinm.2023.102309. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38053536 Free PMC article.
Optimal combinations of delivery modes and components to improve efficacy and sustain long-term effects should also be explored. FUNDING: National Research Foundation, Prime Minister's Office, Singapore, under its Campus for Research Excellence and Technological Enterprise …
Optimal combinations of delivery modes and components to improve efficacy and sustain long-term effects should also be explored. FUND …
Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort Study.
van Goor IWJM, Schouten TJ, Verburg DN, Besselink MG, Bonsing BA, Bosscha K, Brosens LAA, Busch OR, Cirkel GA, van Dam RM, Festen S, Koerkamp BG, van der Harst E, de Hingh IHJT, Intven MPW, Kazemier G, Los M, Meijer GJ, de Meijer VE, Nieuwenhuijs VB, Roos D, Schreinemakers JMJ, Stommel MWJ, Verdonk RC, van Santvoort HC, Daamen LA, Molenaar IQ; Dutch Pancreatic Cancer Group. van Goor IWJM, et al. Among authors: van dam rm. Ann Surg. 2024 Jan 1;279(1):132-137. doi: 10.1097/SLA.0000000000006004. Epub 2023 Jul 17. Ann Surg. 2024. PMID: 37450706 Free PMC article.
OBJECTIVE: To develop a prediction model for long-term (5 years) disease-free survival (DFS) after the resection of pancreatic ductal adenocarcinoma (PDAC). BACKGROUND: Despite high recurrence rates, ~10% of patients have long-term DFS after PDAC resection. A model …
OBJECTIVE: To develop a prediction model for long-term (5 years) disease-free survival (DFS) after the resection of pancreatic ductal …
Effects of dietary quality, physical activity and weight loss on glucose homeostasis in persons with and without prediabetes in the PREMIER trial.
Gradinariu V, Ard J, van Dam RM. Gradinariu V, et al. Among authors: van dam rm. Diabetes Obes Metab. 2023 Sep;25(9):2714-2722. doi: 10.1111/dom.15160. Epub 2023 Jun 13. Diabetes Obes Metab. 2023. PMID: 37311720
AIMS: We examined the contribution of changes in diet quality, physical activity and weight loss to improvements in insulin resistance (HOMA-IR index) and fasting glucose concentrations in a long-term behavioural trial. Furthermore, we compared the effects of lifestyle cha …
AIMS: We examined the contribution of changes in diet quality, physical activity and weight loss to improvements in insulin resistance (HOMA …
Development of "LvL UP 1.0": a smartphone-based, conversational agent-delivered holistic lifestyle intervention for the prevention of non-communicable diseases and common mental disorders.
Castro O, Mair JL, Salamanca-Sanabria A, Alattas A, Keller R, Zheng S, Jabir A, Lin X, Frese BF, Lim CS, Santhanam P, van Dam RM, Car J, Lee J, Tai ES, Fleisch E, von Wangenheim F, Tudor Car L, Müller-Riemenschneider F, Kowatsch T. Castro O, et al. Among authors: van dam rm. Front Digit Health. 2023 May 10;5:1039171. doi: 10.3389/fdgth.2023.1039171. eCollection 2023. Front Digit Health. 2023. PMID: 37234382 Free PMC article.
In addition to the intervention components, formative research also stressed the need to introduce engagement-specific components to maximise uptake and long-term use. LvL UP includes a motivational interviewing and storytelling approach to deliver the coaching sessions, a …
In addition to the intervention components, formative research also stressed the need to introduce engagement-specific components to maximis …
Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, observational cohort study.
Henry AC, van Dongen JC, van Goor IWJM, Smits FJ, Nagelhout A, Besselink MG, Busch OR, Bonsing BA, Bosscha K, van Dam RM, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IH, van der Kolk M, Liem MSL, de Meijer VE, Patijn GA, Roos D, Schreinemakers JM, Wit F, Daamen LA, van Santvoort HC, Molenaar IQ, van Eijck CHJ. Henry AC, et al. Among authors: van dam rm. BJS Open. 2023 Mar 7;7(2):zrac174. doi: 10.1093/bjsopen/zrac174. BJS Open. 2023. PMID: 36959099 Free PMC article.
BACKGROUND: The causal pathway between complications after pancreatic cancer resection and impaired long-term survival remains unknown. The aim of this study was to investigate the impact of complications after pancreatic cancer resection on disease-free interval and overa …
BACKGROUND: The causal pathway between complications after pancreatic cancer resection and impaired long-term survival remains unknow …
Outcome of Pancreatic Surgery During the First 6 Years of a Mandatory Audit Within the Dutch Pancreatic Cancer Group.
Suurmeijer JA, Henry AC, Bonsing BA, Bosscha K, van Dam RM, van Eijck CH, Gerhards MF, van der Harst E, de Hingh IH, Intven MP, Kazemier G, Wilmink JW, Lips DJ, Wit F, de Meijer VE, Molenaar IQ, Patijn GA, van der Schelling GP, Stommel MWJ, Busch OR, Groot Koerkamp B, van Santvoort HC, Besselink MG; Dutch Pancreatic Cancer Group. Suurmeijer JA, et al. Among authors: van dam rm. Ann Surg. 2023 Aug 1;278(2):260-266. doi: 10.1097/SLA.0000000000005628. Epub 2022 Jul 22. Ann Surg. 2023. PMID: 35866656
Patient, tumor, and treatment characteristics were compared between 3 time periods (2014-2015, 2016-2017, and 2018-2019). Short-term surgical outcome was investigated using multilevel multivariable logistic regression analyses. ...
Patient, tumor, and treatment characteristics were compared between 3 time periods (2014-2015, 2016-2017, and 2018-2019). Short-term
Short- and Long-Term Outcomes of Pancreatic Cancer Resection in Elderly Patients: A Nationwide Analysis.
Henry AC, Schouten TJ, Daamen LA, Walma MS, Noordzij P, Cirkel GA, Los M, Besselink MG, Busch OR, Bonsing BA, Bosscha K, van Dam RM, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IHJT, Kazemier G, Liem MS, de Meijer VE, Nieuwenhuijs VB, Roos D, Schreinemakers JMJ, Stommel MWJ, Molenaar IQ, van Santvoort HC; Dutch Pancreatic Cancer Group. Henry AC, et al. Among authors: van dam rm. Ann Surg Oncol. 2022 Sep;29(9):6031-6042. doi: 10.1245/s10434-022-11831-7. Epub 2022 Jun 2. Ann Surg Oncol. 2022. PMID: 35653069 Free PMC article.
BACKGROUND: The number of elderly patients with pancreatic cancer is growing, however clinical data on the short-term outcomes, rate of adjuvant chemotherapy, and survival in these patients are limited and we therefore performed a nationwide analysis. ...
BACKGROUND: The number of elderly patients with pancreatic cancer is growing, however clinical data on the short-term outcomes, rate …
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.
Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Tienhoven G, van Eijck CHJ; Dutch Pancreatic Cancer Group. Versteijne E, et al. Among authors: van dam rm. J Clin Oncol. 2022 Apr 10;40(11):1220-1230. doi: 10.1200/JCO.21.02233. Epub 2022 Jan 27. J Clin Oncol. 2022. PMID: 35084987 Clinical Trial.
Initial results of the PREOPANC trial failed to demonstrate a statistically significant overall survival (OS) benefit. The long-term results are reported. METHODS: In this multicenter, phase III trial, patients with resectable and borderline resectable pancreatic cancer we …
Initial results of the PREOPANC trial failed to demonstrate a statistically significant overall survival (OS) benefit. The long-term
64 results